OPA1 functions in mitochondria and dysfunctions in optic nerve

Area of Science:

• Ophthalmology
• Genetics
• Cell Biology

Background:

• Dominant Optic Atrophy (DOA) is a blinding disease primarily affecting retinal ganglion cells (RGCs).
• The OPA1 gene, encoding an intra-mitochondrial dynamin, is the major genetic cause of DOA.
• The ubiquitous expression of OPA1 raises questions about the specific pathophysiology in RGCs.

Purpose of the Study:

• To review fundamental knowledge of OPA1 functions and regulations.
• To highlight OPA1's roles in mitochondrial respiration, membrane dynamics, and apoptosis.
• To analyze RGC mitochondrial physiology and data from OPA1 mutation animal models in the context of DOA.

Main Methods:

• Literature review of OPA1 functions, regulations, and mitochondrial dynamics.
• Analysis of existing data from animal models with OPA1 mutations.
• Examination of RGC mitochondrial network physiology.

Main Results:

• OPA1 is crucial for mitochondrial inner membrane structure, respiration, and apoptosis.
• RGC mitochondria, while not uniquely structured at a molecular level, are vulnerable to various stressors.
• OPA1 mutations in mouse models demonstrate compromised RGC function and survival due to mitochondrial dysfunction.

Conclusions:

• OPA1's role in mitochondrial health is critical for RGC survival.
• RGC mitochondria are susceptible to environmental and intrinsic insults, leading to DOA.
• Current knowledge and available models provide a foundation for initiating and evaluating therapeutic trials for DOA.